Related Posts
What Causes SDTM, ADaM and SEND Validation Failures
SDTM, ADaM, and SEND datasets form the backbone of regulatory submissions to the FDA, PMDA, and other agencies. Yet validation failures in these datasets remain one of the most common obstacles to achieving submission readiness. Understanding why these failures occur...
How to Fix SEND Compliance Gaps in Mid-Sized Biotechs
Learn how mid-sized biotechs can fix internal SEND compliance gaps. PointCross explains workflow issues, traceability solutions, and submission readiness steps.
SEND Validation for FDA and PMDA in 2026
Why SEND Validation Matters for Your FDA and PMDA Submissions Your nonclinical study data must clear FDA validation before a reviewer ever sees it. A malformed dataset, missing Trial Summary file, or mismatch between your SEND package and study report...
Produce a Study Report + SEND Dataset in 2–3 Weeks
Most nonclinical CROs take 8 to 10 weeks to deliver a study report and its SEND dataset, because two teams rebuild the same data twice. Here's how producing both from one governed source cuts that to 2 to 3 weeks...
